Healthcare & Life Sciences News and Articles

Google News – Clinical Trials External News

Norroy receives China’s clearance for Phase III study of 177Lu-NYM032 - Clinical Trials Arena

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

WCG releases checklist to speed protocol amendment implementation at clinical trial sites - The Clinical Trial Vanguard

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Fortrea’s $45M Early Phase Deal Sets a 90-Day Test for Sponsors With Active Studies - The Clinical Trial Vanguard

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Ultragenyx’s apazunersen fails Phase 3 primary endpoint in Angelman syndrome - The Clinical Trial Vanguard

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Markel launches rare disease trial travel reimbursement scheme - Clinical Trials Arena

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Eledon Pharmaceuticals Announces Islet Cell Transplantation - GlobeNewswire

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference - GlobeNewswire

news.google.com · 03 Sep 2026

Google News – Digital Health External News

HEALWELL AI, Converge Health Iowa to Deploy Clinical AI Tools Across US Statewide HIE - Digital Health News

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Growth of Clinical Trials, Lawsuits Spotlight Cannabis IP Divide - Bloomberg Law News

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Ivonescimab Meets Overall Survival Endpoint Against Pembrolizumab in Phase III Trial - The Clinical Trial Vanguard

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

NSABP B-59 Failed. The Real Question Is Why We Keep Designing Trials That Can’t Detect the Signal. - The Clinical Trial Vanguard

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

TScan Therapeutics cuts 75% of workforce, pauses Phase 3 ALLOHA-2 trial for TSC-101 - The Clinical Trial Vanguard

news.google.com · 03 Sep 2026

Google News – Pharmaceuticals External News

PMV Pharmaceuticals Structures Warrant Offering Around Rezatapopt NDA Acceptance - The Clinical Trial Vanguard

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Novartis halts CAR-T therapy trials due to three patient fatalities, BMS follows - BioProcess International

news.google.com · 03 Sep 2026

Google News – Pharmaceuticals External News

West Chester's Verrica Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial for YCANTH® in Common Warts - BioBuzz

news.google.com · 03 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Norroy receives China’s clearance for Phase III study of 177Lu-NYM032 - Clinical Trials Arena

WCG releases checklist to speed protocol amendment implementation at clinical trial sites - The Clinical Trial Vanguard

Fortrea’s $45M Early Phase Deal Sets a 90-Day Test for Sponsors With Active Studies - The Clinical Trial Vanguard

Ultragenyx’s apazunersen fails Phase 3 primary endpoint in Angelman syndrome - The Clinical Trial Vanguard

Markel launches rare disease trial travel reimbursement scheme - Clinical Trials Arena

Eledon Pharmaceuticals Announces Islet Cell Transplantation - GlobeNewswire

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference - GlobeNewswire

HEALWELL AI, Converge Health Iowa to Deploy Clinical AI Tools Across US Statewide HIE - Digital Health News

Growth of Clinical Trials, Lawsuits Spotlight Cannabis IP Divide - Bloomberg Law News

Ivonescimab Meets Overall Survival Endpoint Against Pembrolizumab in Phase III Trial - The Clinical Trial Vanguard

NSABP B-59 Failed. The Real Question Is Why We Keep Designing Trials That Can’t Detect the Signal. - The Clinical Trial Vanguard

TScan Therapeutics cuts 75% of workforce, pauses Phase 3 ALLOHA-2 trial for TSC-101 - The Clinical Trial Vanguard

PMV Pharmaceuticals Structures Warrant Offering Around Rezatapopt NDA Acceptance - The Clinical Trial Vanguard

Novartis halts CAR-T therapy trials due to three patient fatalities, BMS follows - BioProcess International

West Chester's Verrica Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial for YCANTH® in Common Warts - BioBuzz